Whitaker-Myers Wealth Managers’s Johnson & Johnson JNJ Stock Holding History

Whitaker-Myers Wealth Managers’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,129	Closed	-$308K	–	124
2024 Q4	$308K	Buy	+2,129	New	+$330K	0.09%	89

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Whitaker-Myers Wealth Managers's JNJ Position: Q1 2025 in Review

Whitaker-Myers Wealth Managers sold out of Johnson & Johnson (JNJ) in Q1 2025, closing a stake of 2,129 shares — an estimated $308K sold.

Whitaker-Myers Wealth Managers first reported a position in JNJ in Q4 2024 and held it in 1 quarter. The position peaked at $308K in Q4 2024. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

Whitaker-Myers Wealth Managers reported no remaining Johnson & Johnson position as of Q1 2025 after selling out during the quarter.
Whitaker-Myers Wealth Managers sold 2,129 Johnson & Johnson shares in Q1 2025, an estimated $308K.
Whitaker-Myers Wealth Managers first reported a position in Johnson & Johnson in Q4 2024 and held it in 1 quarter.
Whitaker-Myers Wealth Managers's Johnson & Johnson position peaked at $308K in Q4 2024.
4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Whitaker-Myers Wealth Managers's 13F filing for Q1 2025, filed 14 Apr 2025.